Anti-Cancer Drugs Journal Issues Research Articles in August 2022 Edition
July 18, 2022
July 18, 2022
LONDON, England, July 18 -- Anti-Cancer Drugs, a journal that says it reports clinical and experimental results related to anti-cancer drugs and welcomes contributions on anti-cancer drug design, drug delivery, pharmacology, hormonal and biological modalities and chemotherapy evaluation, published research articles on the following topics in its August 2022 edition:
Pre-Clinical Reports:
* The identification of the anthracycline aclarubicin as an effective cytotoxic ag . . .
Pre-Clinical Reports:
* The identification of the anthracycline aclarubicin as an effective cytotoxic ag . . .